A new product called "phyto-hormone" was designed to replace the hormone replacement therapy (HRT) in recent years. This development is associated with two historical contexts: the announcement of the risks associated with hormone replacement therapy (HRT) for postmenopausal women in 2002, and a change in public perception of consumers and pharmaceutical companies about medicinal plants. Some plants used by traditional communities for symptoms associated with menopause have been scientifically researched in recent decades and, as a result, a new category of medicine was established. From the actor-network theory and translation, Bruno Latour analyzes the construction of this class of drug, and how the idea of "natural" was re-signified by the actors involved in the socio-technical network.
menopause; HRT; medicinal plants; nature